Albert D. Dyrness Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

Albert D. Dyrness is Director of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of SONN, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2025, when has been sold 4,537 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Albert D. Dyrness Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Sale (or disposition) back to the issuer	-	4,537 Reduced 100.0%	0 Common Stock
Dec 11 2023	BUY Grant, award, or other acquisition	-	373 Added 40.99%	537 Common Stock
Jul 11 2023	BUY Grant, award, or other acquisition	-	4,000 Added 46.85%	4,537 Common Stock
May 30 2023	BUY Open market or private purchase	$10,929 $0.47 p/Share	23,255 Added 44.54%	28,962 Common Stock
Dec 14 2022	BUY Grant, award, or other acquisition	-	3,770 Added 10.88%	30,893 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	14,152 Added 34.29%	27,123 Common Stock

Also insider at

PURR

Hyperliquid Strategies Inc

ADD

Albert D. Dyrness

Director

Princeton,, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Value

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Track Activities on SONN

Account